- Global Pharma News & Resources

Press Releases - 2019-11-11

Date Title Company
11-Nov-2019 CO.DON AG: co.don Aktiengesellschaft completes capital increase CO.DON AG
11-Nov-2019 Results for Bimagrumab in Obesity and Type 2 Diabetes presented by MorphoSys's Partner (news with additional features) MorphoSys AG
11-Nov-2019 Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics Cohen Veterans Bioscience
11-Nov-2019 Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019 Mallinckrodt plc
11-Nov-2019 New data show non-inferiority of efficacy for subcutaneous formulation of CT-P13 (biosimilar infliximab) to intravenous formulation of CT-P13 in people with rheumatoid arthritis Celltrion Healthcare
11-Nov-2019 First Phase 3 results from DISCOVER studies evaluating Tremfya in Psoriatic Arthritis The Janssen Pharmaceutical Companies
11-Nov-2019 Centerline Biomedical's Intra-Operative Positioning System Technology Showcased at VIVA Disruptive Technologies Session Centerline Biomedical
11-Nov-2019 Photothermal Spectroscopy Corp and Bio-Rad Form Partnership in the Field of Simultaneous IR and Raman Spectroscopy Bio-Rad Laboratories, Inc
11-Nov-2019 F2G Receives US FDA Breakthrough Therapy Designation for Olorofim F2G Ltd
11-Nov-2019 evitria Opens its New Head Office in Scandinavia evitria AG
11-Nov-2019 Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment ABCAM PLC
11-Nov-2019 GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy GW Pharmaceuticals plc
11-Nov-2019 UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP UCB
11-Nov-2019 Heidelberg Pharma AG: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45 Heidelberg Pharma AG
11-Nov-2019 Autolus Therapeutics Presents Preclinical Data on AUT06NG at the SITC Annual Meeting Autolus Therapeutics plc
11-Nov-2019 Roxadustat Phase III programme pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease AstraZeneca
11-Nov-2019 World’s First Cyclic IMS Mass Spectrometer Installed at Aston University Aston University
11-Nov-2019 BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019 BioNTech SE
11-Nov-2019 Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults Mallinckrodt